Patents Represented by Attorney Poter Wright Morris & Arthur
  • Patent number: 8138326
    Abstract: The present invention relates to a method and kit for quantitative and qualitative determination of human papillomavirus, HPV, in a sample. More precisely, for quantitative and qualitative determination of oncogenic HPV to predict the risk of HPV infection resulting in cervical carcinoma. The method and kit enable simultaneous measurement of several oncogenic HPV types.
    Type: Grant
    Filed: October 1, 2003
    Date of Patent: March 20, 2012
    Assignee: Cepheid Corporation
    Inventors: Ulf Gyllensten, Martin Moberg